MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy
BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.
It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.
You may also like
Gainers
Latest Crypto News
BlackRock: Tokenization is evolving at a pace comparable to the early Internet, poised for significant growth
Whale "pension-usdt.eth" yesterday saw its ETH long position fall below the average price, with a position size reaching $56 million.
Dark Pool DEX HumidiFi to Launch ICO, Leading in Trading Volume Among Solana Ecosystem DEXs
「Bankrupt」 trader James Wynn opened a new 40x leverage BTC long position. Last week, he predicted that BTC would drop to $67,000 within the week.
DeFi protocol Zoo Finance has announced the completion of an $8 million strategic fundraising round.
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:bd@weex.com
VIP Services:support@weex.com